Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery
Description
The success of the mRNA vaccine against COVID-19 has garnered significant interest in the development of mRNA therapeutics against other diseases, but there remains a strong need for a stable and versatile delivery platform for these therapeutics. In
